Benralizumab: a unique IL-5 inhibitor for severe asthma

Overview of attention for article published in Journal of Asthma and Allergy, April 2016

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (88th percentile)
Average Attention Score compared to outputs of the same age and source

Mentioned by

blogs: 1 blog
twitter: 9 X users

wikipedia: 1 Wikipedia page

Citations

dimensions_citation: 76 Dimensions

Readers on

mendeley: 76 Mendeley

Summary Blogs X Wikipedia Dimensions citations

So far, Dimensions has found 76 publications that cite this research output.

76

The most recent citing publications are shown below. View all 76 publications that cite this research output on Dimensions.

Navigating the Terrain: Type 2 Cytokines and Biologic intervention in Severe Eosinophilic Asthma

Book chapter (August 2024)

Application of nano- and micro-particle-based approaches for selected bronchodilators in management of asthma

Article in 3 Biotech (August 2024)

Effect of benralizumab on histopathology and inflammatory signatures in a clinical cohort of eosinophilic esophagitis

Article in Diseases of the Esophagus (July 2024)